Roche

ROG.SWPre-clinical

Basel, Switzerlandroche.com

F. Hoffmann-La Roche Ltd is a Swiss multinational healthcare company headquartered in Basel, with over 125 years of history in pharmaceutical and diagnostic innovation. The company operates through two main divisions - Roche Pharmaceuticals and Roche Diagnostics - focusing on preventing, stopping, and curing diseases with high societal burden. Roche is publicly traded and maintains a strong commitment to research and development, with a strategy centered on personalized healthcare and integrated diagnostic-therapeutic solutions.

Market Cap

$74.6B

Employees

100,000+

Focus

DiagnosticsSmall Molecules

ROG.SW · Stock Price

USD 179.11+116.42 (+185.69%)

Historical price data

AI Company Overview

Technology Platform

Integrated pharmaceuticals and diagnostics platform combining personalized medicine, AI-driven healthcare solutions, and comprehensive biomarker-based treatments. Recently expanded AI capabilities through NVIDIA partnership for accelerated therapeutic development.

Pipeline Snapshot

1000

1000 drugs in pipeline, 684 in Phase 3

Drug	Indication	Stage
TAC + NX	Breast Cancer	Phase 3
orlistat [Xenical]	Obesity	Phase 3
trastuzumab (Herceptin®) + anastrazole (Arimidex®)	Breast Cancer	Phase 3
Methoxy polyethylene glycol-epoetin beta (C.E.R.A.)	Anemia	Phase 3
Rituximab	Follicular Lymphoma	Phase 3

FDA Approved Drugs

VALIUMNDANov 15, 1963

Opportunities

Roche is positioned to capitalize on the growing personalized medicine market, AI-driven healthcare innovation, and increasing global demand for integrated diagnostic-therapeutic solutions.

The company's recent NVIDIA AI factory deployment and focus on early disease detection present significant growth opportunities.

Risk Factors

Key risks include intense competition from established pharmaceutical and diagnostic companies, regulatory challenges across multiple jurisdictions, and potential patent expirations on key products.

Healthcare policy changes and pricing pressures could also impact profitability.

Competitive Landscape

Roche competes with major pharmaceutical companies like Novartis, Pfizer, and Johnson & Johnson in therapeutics, while facing competition from Abbott, Siemens Healthineers, and Danaher in diagnostics. The company's unique integrated pharma-diagnostics model provides competitive differentiation in the personalized healthcare space.

Publications

Patents

Pipeline

1000

FDA Approvals